The medications are delivered using injectable route of administration. This route is convenient and offers greater bioavailability as compared to oral route of administration. There are technological advancements in devices used for injection of medicines. These modifications allow patients to take the medications daily using injectable route of administration. The new products such as auto-injectors, pre-filled syringes, pen-injectors, etc. are proving to be ground breaking technologies in this segment. These advancements are boosting the growth rate of the market over the conventional injectables.

The global Injectable Drug Delivery market size was estimated to be at USD XXX million in 2019, and is expected to grow at a CAGR of XX% during forecast period to reach USD XXX million in 2027.

Market Dynamics:

Increasing new product launches, increasing patient population suffering from chronic diseases, research and development for the introduction of novel products to minimize the unmet medical needs, technological advancements, etc. are some of the factors that are fueling the growth of the market. Product recalls and stringent regulations may hinder the growth of the market during forecast period. The increased use of injectables for medications without skilled professionals is creating opportunity for manufacturers to focus on introducing such products.

COVID-19 Impact:

The impact of COVID-19 pandemic has resulted in the disruption of production as well as distribution network due to logistic issues. Moreover, the impact on patient visits and shift of regular medical care to COVID care have resulted in negative impact on the global Injectable Drug Delivery market. However, the COVID-19 pandemic has created huge demand for the injectable products and hence resulted in short term growth of the global injectable drug delivery market.

Global Injectable Drug Delivery Market

Source: Precise Market Intelligence, 2020


The market has been segmented based on form, indication, end user and region.

  • By Device Type
    • Pre-filled Syringes
    • Auto-injectors
    • Pen-injectors
    • Conventional Injectables
    • Wearables
    • Others
  • By Application
    • Hormonal Disorders
    • Autoimmune Disorders
    • Diabetes
    • Oncology
    • Others
  • By End Users
    • Hospitals
    • Clinics
    • Homecare Settings
  • By Region
    • North America (U.S., Canada)
    • Europe (U.K., France, Germany, Italy, Spain, and rest of Europe)
    • Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
    • South America (Brazil, Mexico, and Rest of South America)
    • Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa)

Based on device type, the conventional injectables segment is expected to remain dominant throughout the forecast period due to high adoption. Based on application, oncology segment accounted to highest market share. While, the hospitals segment dominated the end users, North America has the largest market share among regions.

Injectable Drug Delivery Market, By Region, 2019

Source: Precise Market Intelligence, 2020

Competition Landscape:

The prominent companies in the market are; Eli Lilly and Company, BD (Becton, Dickinson and Company), Schott AG, Insulet Corporation, ypsomed, Pfizer, Inc., Baxter International Inc., Unilife Corporation, B. Braun Melsungen, and others.

For better understanding of revenue contribution of each technology to the Injectable Drug Delivery Market, ask an expert analyst